We survey 146 papers analyzing “bias” in NLP systems, finding that their motivations are often vague, inconsistent, and lacking in normative reasoning, despite the fact that analyzing “bias” is an inherently normative process.
The objective of this guideline is to provide medical device manufacturers and notified bodies instructions and to provide them with a concrete checklist to understand what the expectations of the notified bodies are, to promote step-by-step implementation of safety of medical devices, that implement artificial intelligence methods, in particular machine learning, to compensate for the lack of a harmonized standard (in the interim) to the greatest extent possible.
This paper contributes the first human-centered observational study of a deep learning system deployed directly in clinical care with patients. Through field observations and interviews at eleven clinics across Thailand, we explored the expectations and realities that nurses encounter in bringing a deep learning model into their clinical practices. First, we outline typical eye-screening workflows and challenges that nurses experience when screening hundreds of patients. Then, we explore the expectations nurses have for an AI-assisted eye screening process. Next, we present a human-centered, observational study of the deep learning system used in clinical care, examining nurses’ experiences with the system, and the socio-environmental factors that impacted system performance. Finally, we conclude with a discussion around applications of HCI methods to the evaluation of deep learning algorithms in clinical environments.
In their efforts to tackle the COVID-19 crisis, decision makers are considering the development and use of smartphone applications for contact tracing. Even though these applications differ in technology and methods, there is an increasing concern about their implications for privacy and human rights. Here we propose a framework to evaluate their suitability in terms of impact on the users, employed technology and governance methods.
With new legislation on data protection in the EU now in place, our greatest challenge moving into 2020 is to ensure that this legislation produces the promised results. This includes ensuring that new rules on ePrivacy remain firmly on the EU agenda. Awareness of the issues surrounding data protection and privacy and the importance of rotecting these fundamental rights is at an all time high and we cannot allow this momentum to decline.
Artificial intelligence and machine learning technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated during the delivery of health care every day. Medical device manufacturers are using these technologies to innovate their products to better assist health care providers and improve patient care. The FDA is considering a total product lifecycle-based regulatory framework for these technologies.